Newton, Massachusetts Clinical Trials

A listing of Newton, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 114 clinical trials
Acne_Trial_CheckOverallContact  

qa

US-Site 1
 (6.0 away)
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Prospective Randomized Placebo-Controlled Trial of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE) (SURVIVE)

The primary purpose of this study is to determine whether adding SurVaxM to standard chemotherapy with temozolomide is better than treatment with temozolomide alone for patients with newly diagnosed glioblastoma. This study is designed to compare the duration of survival in patients with newly diagnosed glioblastoma receiving temozolomide plus SurVaxM …

Dana Farber Cancer Institute
 (4.5 away) Contact site
  • 0 views
  • 02 Dec, 2024
  • +9 other locations
Personalized Performance Optimization Platform (P-POP)

Crews of future long-duration exploration missions will have to cope with a wide range of stressors that present significant challenges for maintaining optimal performance. Crews will have to operate under conditions of high workload, reduced sleep and circadian dysregulation, limited sensory stimulation, confinement and extended separation from family and friends, …

Accepts healthy volunteers
MIT Media Lab
 (4.4 away) Contact site
  • 0 views
  • 21 May, 2025
  • 1 location
Automated Inhaler Monitoring for Asthma Medication Usage (AIM)

The goal of this clinical trial is to evaluate the aflo™ digital platform's ability to improve inhaler use technique and asthma control for children, adolescents, and adults with uncontrolled asthma. The main questions the trial aims to answer are:Does the platform improve medication adherence and inhaler technique, as measured by …

Boston Children's Hospital
 (5.0 away) Contact site
  • 0 views
  • 20 Mar, 2026
  • 1 location
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

melanoma
cancer
measurable disease
neutrophil count
investigational treatment
Massachusetts General Hospital Cancer Center
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.

Massachusetts General Hospital
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Wellbeing Stress Reduction and Social Cognition

There are many ways to improve wellbeing. This study will compare two 8-week wellbeing training programs. In addition to looking at how well the programs reduce stress and enhance wellbeing, the investigators will also ask questions about how these programs influence cognition and decision making.

MGH
 (6.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study Evaluating JUV DERM VOLUMA XC Injectable Gel for Correction of Temple Hollowing in Adult Participants Over 22 Years Old

The objectives of this study are to evaluate the safety and effectiveness of Juvederm Voluma XC injectable gel in adult participants seeking correction of temple hollowing

Skincare Physicians
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +14 other locations
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Dana-Farber Cancer Institute
 (5.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
A Multinational Randomized Double-blind Placebo-controlled Study to Assess the Efficacy Pharmacodynamics Pharmacokinetics and Safety of Venglustat in Late-onset GM2

Primary Objectives: Primary population (adult participants with late-onset GM2 gangliosidosis): To assess the efficacy and pharmacodynamics (PD) of daily oral dosing of venglustat when administered over a 104-week period Secondary population (participants with juvenile/adolescent late-onset GM2 gangliosidosis, GM1 gangliosidosis, saposin C deficiency, sialidosis type 1 or juvenile/adult galactosialidosis): To assess …

Investigational Site Number 8400002
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations